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Background: Transfemoral aortic valve replacement (TAVR) using the Edwards SAPIEN valve is usually performed under general anesthesia (GA). 
We aimed to evaluate the feasibility and safety of performing TAVR under conscious sedation and local anesthesia (LA) and to compare the clinical 
outcomes with another group of patients who underwent TAVR under GA.
Methods: The analysis included 142 consecutive high-risk patients undergoing transfemoral implantation of the Edwards SAPIEN valve and 
included in a prospective registry. The decision to perform GA or LA was made by an experienced anesthesiologist who was actively involved in all 
procedures. The clinical outcomes of these two groups were compared.
Results: LA was utilized in 107 patients (75.4%) whereas GA was used in 35 (24.6%). Baseline clinical characteristics of the two groups were 
similar, except for higher logistic EuroSCOREs and prior stroke rates in the LA group (39.6±19.7 vs. 31.1±18.5, p=0.02) (27.1% vs. 9.7%, p=0.04), 
respectively. Of the patients who underwent LA, 14 (13.1%) converted to GA. Surgical access of the femoral artery was performed more commonly in 
the GA group (68.6% vs. 31.8%, p=0.02). Procedure duration was significantly shorter in the LA group (117.5±68.2 minutes vs. 156.2±84.3, p=0.03) 
as was intensive care unit stay (48.2 vs. 83.7 hours, p=0.02, respectively). In-hospital death rate was lower in the LA group as well (4.7% vs. 22.9%, 
p=0.01)
Conclusion: Performing transfemoral TAVR under conscious sedation and LA using the Edwards SAPIEN valve is feasible in the majority of patients 
and is associated with better clinical outcome than a comparable group of patients who underwent the procedure under GA. LA should be the 
default strategy for this high-risk patient group undergoing transfemoral TAVR.
